8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) September 14, 2007

ICU Medical, Inc.
(Exact name of registrant as specified in its charter)

DELAWARE	0-19974	33-0022692
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

951 Calle Amanecer, San Clemente, California	92673
(Address of principal executive offices)	(Zip Code)

Registrant's telephone number, including area code:   (949) 366-2183

________________________________________________________________________________
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
	[   ]	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
	[   ]	Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12)
	[   ]	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
	[   ]	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01. Other Events.

Other Events

The United States District Court for the Central District of California on September 14, 2007 granted ICU Medical, Inc.'s motion for summary judgment of non-infringement against Medegen LLC.

Item 9.01. Financial Statements and Exhibits.

Financial Statements and Exhibits

(c) Exhibits

99.1 Press release, dated September 17, 2007 entitled, "ICU Medical, Inc. Wins Summary Judgment in Medegen Patent Lawsuit".

SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	ICU Medical, Inc. (Registrant)
September 17, 2007 (Date)	/s/   FRANCIS J. O'BRIEN Francis J. O'Brien Secretary, Treasurer and Chief Financial Officer

Exhibit Index
99.1	Press release dated September 17, 2007

EX-99.1

EXHIBIT 99.1

ICU Medical, Inc. Wins Summary Judgment in Medegen Patent Lawsuit

SAN CLEMENTE, Calif., Sept. 17, 2007 (PRIME NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leading low cost manufacturer of safe medical connectors, custom medical products and critical care devices, announced that today the United States District Court for the Central District of California granted ICU Medical's motion for summary judgment of non-infringement of Medegen MMS's patent. Medegen had filed a lawsuit in 2006 against ICU Medical alleging that ICU Medical infringes one of Medegen's patents by offering for sale and selling the CLC2000 medical connector. Frank O'Brien, ICU Medical's Chief Financial Officer, commented, "We believed all along that we were not infringing Medegen's patent and are very pleased that the Court agrees with us."

Still pending are ICU Medical's claims that the patent Medegen asserted against ICU Medical is invalid and unenforceable due to inequitable conduct of Medegen before the United States Patent and Trademark Office. ICU Medical intends to vigorously pursue its claims. ICU Medical is represented by Morrison & Foerster LLP.

CONTACT:  ICU Medical, Inc.
          Francis J. O'Brien, Chief Financial Officer
          (949) 366-2183

          Integrated Corporate Relations
          John F. Mills, Managing Director
          (310) 395-2215